These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 17070085

  • 1. [Cervical cancer screening and associated treatment costs in France].
    Bergeron C, Breugelmans JG, Bouée S, Lorans C, Bénard S, Rémy V.
    Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness of adding human papilloma virus testing to a managed care cervical cancer screening program.
    Lonky NM, Hunter MI, Sadeghi M, Edwards G, Bajamundi K, Monk BJ.
    J Low Genit Tract Dis; 2007 Oct; 11(4):258-64. PubMed ID: 17917570
    [Abstract] [Full Text] [Related]

  • 4. Ambulatory care visits for Pap tests, abnormal Pap test results, and cervical cancer procedures in the United States.
    Saraiya M, McCaig LF, Ekwueme DU.
    Am J Manag Care; 2010 Jun 01; 16(6):e137-44. PubMed ID: 20536271
    [Abstract] [Full Text] [Related]

  • 5. Cervical cancer screening in a rural population of Zimbabwe.
    Thistle PJ, Chirenje ZM.
    Cent Afr J Med; 1997 Sep 01; 43(9):246-51. PubMed ID: 9509642
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cost-effectiveness analysis of the introduction of a quadrivalent human papillomavirus vaccine in France.
    Bergeron C, Largeron N, McAllister R, Mathevet P, Remy V.
    Int J Technol Assess Health Care; 2008 Sep 01; 24(1):10-9. PubMed ID: 18218164
    [Abstract] [Full Text] [Related]

  • 8. Economic burden associated with the management of cervical cancer, cervical dysplasia and genital warts in Belgium.
    Annemans L, Rémy V, Lamure E, Spaepen E, Lamotte M, Muchada JP, Largeron N.
    J Med Econ; 2008 Sep 01; 11(1):135-50. PubMed ID: 19450115
    [Abstract] [Full Text] [Related]

  • 9. Pap test--with or without vaginal smear?
    Milicić-Juhas V, Perić M, Pajtler M, Prvulović I, Curzik D.
    Coll Antropol; 2010 Mar 01; 34(1):69-74. PubMed ID: 20437636
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening.
    Thiry N, De Laet C, Hulstaert F, Neyt M, Huybrechts M, Cleemput I.
    Int J Technol Assess Health Care; 2009 Apr 01; 25(2):161-70. PubMed ID: 19366497
    [Abstract] [Full Text] [Related]

  • 12. Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening.
    Bidus MA, Maxwell GL, Kulasingam S, Rose GS, Elkas JC, Chernofsky M, Myers ER.
    Obstet Gynecol; 2006 May 01; 107(5):997-1005. PubMed ID: 16648402
    [Abstract] [Full Text] [Related]

  • 13. Integrating human papillomavirus vaccination in cervical cancer control programmes.
    Franco EL, Coutlée F, Ferenczy A.
    Public Health Genomics; 2009 May 01; 12(5-6):352-61. PubMed ID: 19684447
    [Abstract] [Full Text] [Related]

  • 14. Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis.
    Ginsberg GM, Edejer TT, Lauer JA, Sepulveda C.
    Vaccine; 2009 Oct 09; 27(43):6060-79. PubMed ID: 19647813
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cervical cancer screening with pattern of pap smear. Review of multicenter studies.
    Altaf FJ.
    Saudi Med J; 2006 Oct 09; 27(10):1498-502. PubMed ID: 17013471
    [Abstract] [Full Text] [Related]

  • 17. Epidemiology and costs of screening and management of precancerous lesions of the cervix in Spain.
    Castellsagué X, Rémy V, Puig-Tintoré LM, de la Cuesta RS, Gonzalez-Rojas N, Cohet C.
    J Low Genit Tract Dis; 2009 Jan 09; 13(1):38-45. PubMed ID: 19098605
    [Abstract] [Full Text] [Related]

  • 18. [Integrating HPV testing for primary screening?].
    Riethmuller D, Ramanah R, Pretet JL, Mougin C.
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb 09; 37 Suppl 1():S139-51. PubMed ID: 18191912
    [Abstract] [Full Text] [Related]

  • 19. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?
    Perkins RB, Langrish SM, Stern LJ, Figueroa J, Simon CJ.
    Trop Med Int Health; 2007 Sep 09; 12(9):1018-25. PubMed ID: 17875013
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.